Tumor Necrosis Factor (TNF) Inhibitors: A Clinical Primer
4.5
$ 13.50
In stock
(362)
Product Description
Tumor necrosis factor-α antagonists: Side effects and their management - Indian Journal of Dermatology, Venereology and Leprology
Tumor Necrosis Factor Receptor - an overview
Renal Tumor Necrosis Factor α Contributes to Hypertension in Dahl Salt-Sensitive Rats
What does tumour necrosis factor excess do to the immune system long term?
Tumor Necrosis Factor (TNF) Inhibitors: A Clinical Primer
TNF antagonist sensitizes synovial fibroblasts to ferroptotic cell death in collagen-induced arthritis mouse models
Frontiers Role of tumor necrosis factor-alpha in the central nervous system: a focus on autoimmune disorders
A novel recombinant slow-release TNF α-derived peptide effectively inhibits tumor growth and angiogensis
Biologically Synthesized Rosa rugosa-Based Gold Nanoparticles Suppress Skin Inflammatory Responses via MAPK and NF-κB Signaling Pathway in TNF-α/IFN-γ-Induced HaCaT Keratinocytes
Biomolecules, Free Full-Text
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
Molecular mechanism of ER stress‐induced gene expression of tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL) in macrophages - Huang - 2015 - The FEBS Journal - Wiley Online Library
Tumor necrosis factor alpha delivers exogenous inflammation-related microRNAs to recipient cells with functional targeting capabilities: Molecular Therapy
TNF-α synergises with IFN-γ to induce caspase-8-JAK1/2-STAT1-dependent death of intestinal epithelial cells
Small tumor necrosis factor receptor biologics inhibit the tumor necrosis factor-p38 signalling axis and inflammation
